Degradation Study of Quinapril by UV Spectroscopy
DOI:
https://doi.org/10.56511/JIPBS.2015.v2.i02.pp111-114Abstract
Quinapril hydrochloride is an angiotensin converting enzyme (ACE) inhibitor. It is used to treat hypertension and cardiac failure. The forced degradation studies on drug substance involves photo Acid/base Stress testing, photo degradation, Temperature and or with humidity, Time, pH variation (high and low). In our present research work we have studied the degradation parameters on Quinapril hydrochloride. For this purpose we performed stress testing on the brand of the drug i.e. accupril. According to USP, Quinapril Hydrochloride contains not less than (NLT) 98.5 % and not more than (NMT) 101.5% of (C25H30N2O5.HCl), calculated on anhydrous basis. The result of this study concludes that when chosen brand of Quinapril (Accupril) was introduced in 0.1 N NaOH (basic medium) and 0.1 N HCl (acidic medium) the brand showed no degradation Whereas when the chosen brand was exposed to Ultraviolet light (320 nm) for 30 min, heat and water, Accupril showed no degradation.
Keywords:
Quinapril, UV spectroscopy, Forced degradation, ICH guidelineDownloads
References
Moffat AC, Osselton MD, Widdop B. Clarke’s Analysis of Drugs and Poisons. 3rd ed. London: Pharmaceutical Press; 2004. pp. 1516 – 7.
Sweetman SC. MartindaleThe Complete Drug Reference. 33rd ed. London: Pharmaceutical Press; 2002. pp. 963 – 4.
Kerins DM, Robertson RM, Robertson D. Drugs used for the treatment of myocardial ischemia. In: Hardman JG, Limbird LE, Gilman AG, Goodman and Gilman’s, editors. The Pharmacological Basis of Therapeutics. 10th ed. New York: McGraw Hill, Medical Publishing Division; 2001. p. 841.
Iain B. Squirei, Robert J. Macfadyeni, Kennedy R. Lees', W. Stewart Hillis1"2 & John L.Reid'. Haemodynamic Response And Pharmacokinetics After The First Dose Of Quinapril In Patients With Congestive Heart Failure. Br J Clin Pharmac 1994; 38: 117-123
Cetnarowski-Cropp AB . Quinapril: a new second-generation ACE inhibitor. 1991 May;25(5):499-504.
Culy CR , Jarvis B . Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders. Drugs. 2002;62(2):339-85.
Safila Naveed, Sheeba Urooj and Nimra Waheed. Degradation Studies of Different Brands of Moxifloxac in Available in the Market. International Journal of Current Pharmaceutical Review and Research, 5(4), 110-116; 2014-15
Naveed S, Waheed N, Nazeer S .Degradation Study of Metronidazole in Active and Different Formulation by UV Spectroscopy. J Bioequiv Availab 6: 124-127; 2014 doi:10.4172/jbb.1000191
Published
How to Cite
Issue
Section
Copyright (c) 2015 Safila Naveed, Safeena Nazeer, Nimra Waheed

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.


Journal of Innovations in Pharmaceutical and Biological Sciences is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at